Dudediligence.

Citius Oncology, Inc

CTORNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

105.8M

on 2026-06-30, from 67.9M on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 29-for-1 split; each bar's tip shows the count as filed.

a raise that quarter, at its price

25M50M75M100M29:1 splitMar2024JunSepDecMar2025JunSep$1.75Dec$1.09Mar2026Jun

Newest

$200.0M

S-3 of 2025-09-02. 2 prospectus supplements filed under it since. S-3 ↗

6 of its filings are not read yet.

Warrants

53.95M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

Four quarters of operating cash flow to 2026-06-30 are not all on file.

Raised
DateWhatSharesPriceGrossFiling
2025-12-08Public offering1,284,404$1.09$1.4M424B5 ↗
2025-09-09Public offering with warrants at $1.845,142,858$1.75$9.0M424B5 ↗
2025-09-09Registered direct offering5,142,858not read$100K8-K ↗
2025-07-16Public offering6,818,182$1.32$9.0M424B4 ↗

Also on file: up to $25.0M promissory note agreed 2026-05-05 8-K ↗